Home > Balance Sheet > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Contingent Liabilities

    Back to Balance Sheet
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹394 Cr₹286 Cr₹97 Cr₹12 Cr₹13 Cr

What is the latest Contingent Liabilities ratio of EMCURE PHARMACEUTICALS ?

The latest Contingent Liabilities ratio of EMCURE PHARMACEUTICALS is ₹394 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹394 Cr
Mar2024₹286 Cr
Mar2023₹97 Cr
Mar2022₹12 Cr
Mar2021₹13 Cr

How is Contingent Liabilities of EMCURE PHARMACEUTICALS Trending?

Years Contingent Liabilities % Change
Mar2025 ₹394 Cr
37.98
Mar2024 ₹286 Cr
194.49
Mar2023 ₹97 Cr
703.28
Mar2022 ₹12 Cr
-5.66
Mar2021 ₹13 Cr -

Compare Contingent Liabilities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹30,219.4 Cr 8.4% 11.1% 53.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr 0.6% -4.5% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

8.4%

11.1%

53.8%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses